Promising results for a chronic obstructive pulmonary disease drug
A study conducted on patients with chronic obstructive pulmonary disease (COPD) revealed that mepolizumab reduces shortness of breath and chest infections by up to 20%.
A study conducted on patients with chronic obstructive pulmonary disease (COPD) revealed that mepolizumab reduces shortness of breath and chest infections by up to 20%.
After a relative cessation of the Israeli war machine that annihilated the Gaza Strip over the course of two full years, Palestinian childhood still lives with open wounds, telling chapters of an endless tragedy, and revealing the depth of the pain left by a crushing war on small bodies and…